Terry-Ann Burrell - Apr 26, 2024 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Signature
By: /s/ Christine Bellon, Attorney-in-fact
Stock symbol
BEAM
Transactions as of
Apr 26, 2024
Transactions value $
$0
Form type
4
Date filed
4/29/2024, 04:10 PM
Previous filing
Apr 3, 2024
Next filing
Jun 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BEAM Common Stock Award $0 +12.5K +17.82% $0.00 82.6K Apr 26, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BEAM Stock Option (Right to Buy) Award $0 +25K $0.00 25K Apr 26, 2024 Common Stock 25K $30.87 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") granted to the Reporting Person under the Beam Therapeutics Inc. ("BEAM") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSU vests in three substantially equal annual installments on each of the first three anniversaries of September 30, 2023, subject to the Reporting Person's continued service with BEAM through each vesting date.
F2 This stock option vests in equal monthly installments each month following July 31, 2023 for the subsequent thirty-six months, subject to the Reporting Person's continued service with BEAM through each vesting date.